A pass-or-review checklist for biofabricated materials

What to take away

• Apply this checklist to one version, batch, site, and product use.
• Require a full formulation, not only the biological base.
• Separate bio-based content from biodegradation and compostability.
• Pilot evidence cannot support unrestricted commercial claims.
• Stop when composition, safety, or a mandatory function is unknown.

Review header

Field	Entry
Material and version
Batch and production site
Biological route
Supplied form
Product use
Review date
Reviewer

Biological system

• Organism or biological catalyst is identified at a useful level.
• Biological output is named.
• Feedstock or culture medium is described.
• Engineered-organism status is disclosed where relevant.
• Growth, fermentation, or reaction boundary is mapped.
• Deactivation, purification, or washing is documented.
• Residual cells or biological matter are addressed.

Complete formulation

• Biological component percentage or role is stated.
• Substrate, scaffold, or backing is listed.
• Binder and plasticizer are listed.
• Dye, pigment, and crosslinker are listed.
• Coating, adhesive, and protective finish are listed.
• Composition covers the finished product, not only the base sheet.
• Confidential data were reviewed by a named qualified party.

Bio-based content

• The claim states which component is bio-based.
• Percentage basis and test method are named.
• The tested sample matches the supplied version.
• Chain-of-custody or accounting method is identified.
• Packaging is not confused with product content.
• The result is not presented as a safety or impact score.

USDA BioPreferred's testing-phase definitions distinguish certified products, third-party verification, and bio-based content measured as new organic carbon relative to total organic carbon. Use that result only for the content question it answers.

Manufacturing and scale

• Process stages are mapped from feedstock to shipment.
• Water, energy, nutrients, chemicals, and drying are included.
• Yield and waste use a stated unit and boundary.
• Data identify laboratory, pilot, or commercial scale.
• Multiple batches have been reviewed.
• Contamination and failed-batch controls are documented.
• Capacity, lead time, and minimum order fit the launch.
• Changes to site or scale trigger retesting.

Safety and compliance

• Intended skin, food, inhalation, or occupational exposure is defined.
• Safety documentation covers the finished formulation.
• Restricted substances and residual chemicals are checked.
• Microbial status and allergen questions are addressed where relevant.
• Claims comply with the destination market.
• A qualified reviewer handles medical, protective, or regulated uses.

Product performance

• Test plan comes from the product brief.
• Thickness and density variation are within limits.
• Strength, tear, or puncture meet the use.
• Flex, abrasion, and crease behavior meet the use.
• Wet behavior and humidity response are tested.
• Color and surface finish remain acceptable.
• Seams, bonds, edges, or fasteners are tested.
• Complete-product care is validated.
• Aging limits are stated.

Claims

• "Grown" names what was grown and its role.
• "Waste-fed" identifies the input and preparation.
• "Plastic-free" covers coatings, binders, backing, and adhesives.
• "Lower impact" names baseline, method, boundary, and date.
• "Biodegradable" names sample, environment, time, and residues.
• "Compostable" states home or industrial conditions.
• "Recyclable" names an accepting process for the full material.
• Pilot findings are labeled as pilot findings.

End route

The EPA's consumer guidance on bio-based plastics, recycling, and composting explains that bio-based plastics may or may not be biodegradable and that industrial composting differs from home composting. Apply the same discipline to biofabricated composites: origin does not determine the route.

• Continued use and repair are considered first.
• Disassembly needs are known.
• A named collector accepts every relevant component.
• The route is accessible in the buyer's location.
• Take-back terms state what happens to returned material.
• No disposal claim encourages littering or uncontrolled release.

Decision

Outcome	Meaning
Pass	Defined version meets mandatory needs and claims have support
Pilot only	Controlled use is approved with named limits and monitoring
Review	Specific evidence is missing but no stop condition is triggered
Stop	Identity, safety, compliance, or mandatory performance is unresolved

Record the decision, owner, open items, due date, and retest triggers. These gates compress the twelve-step biofabricated review into a single table.

Required evidence package

Before a commercial pass, assemble:

1. Versioned product brief and mandatory requirements
2. Full material and finished-product composition
3. Biological process and manufacturing flow
4. Supplier and site identification
5. Sampling plan and batch connection
6. Raw performance and safety reports
7. Complete-product care and aging results
8. Claim-to-source table
9. Local end-route confirmation
10. Change-control and retest plan

Do not accept a slide deck as a substitute for raw reports. The approval file needs method, sample, conditions, result, date, and responsible party. When the input is a spun bio-based fiber rather than a grown composite, the bio-based fiber checklist is the right instrument.

Sampling plan

• Samples represent the production run where relevant.
• More than one batch is included.
• Selection was not limited to visually perfect material.
• Conditioning before testing is defined.
• Thickness, moisture, and orientation are recorded.
• Retained samples are stored under stated conditions.
• Failed specimens and outliers remain in the record.

Biological variation is a reason to define control limits and sampling that reveal the range. How much variation to expect differs by route; the biofabricated material routes reference sets that context.

Change control

Require notice before changes to organism, feedstock, medium, site, growth conditions, purification, deactivation, drying, thickness, plasticizer, dye, binder, coating, scaffold, backing, adhesive, batch size, equipment, construction, or care.

For every change, decide which composition, safety, performance, care, claim, and end-route checks must be repeated. "Equivalent" needs criteria. If a scaffold, backing, or substrate is a natural-fiber textile, run the natural fiber checklist for that component.

Escalation points

Send the review to a specialist when the product involves skin sensitization, food contact, medical use, protective equipment, children, microbial exposure, genetic engineering, regulated chemicals, or uncertain waste handling.

If protected information cannot be disclosed, use an independent reviewer under confidentiality. The public claim still needs a clear boundary.

Release check

• Label and copy match the approved version.
• Images do not imply a higher biological share than the formulation.
• Prototype language is removed only where commercial evidence exists.
• Disposal instructions match current local access.
• Sales and customer-service teams use the approved answers.
• A correction owner and process are named.

Common questions

Does a bio-based-content test identify every ingredient?

No. It measures a defined carbon relationship under the stated method. Obtain a formulation for ingredient and component review.

Can a supplier's prototype data support a launch?

Only if the commercial version, process, and variation are represented. Otherwise, restrict approval to a controlled pilot.

Is industrial compostability useful without a facility?

It may describe technical behavior, but it does not provide the owner with a route. Confirm local acceptance before making practical disposal claims.

What changes require retesting?

Common triggers include organism, feedstock, formulation, coating, backing, thickness, color, site, scale, process, and product construction.

Who should approve safety?

A person qualified for the material, exposure, product category, and destination market should review it. Biological origin is not a safety credential.